Am. J. Respir. Crit. Care Med., Volume 156, Number 2, August 1997, 631-636

Tissue Factor Expression and Fibrin Deposition in the Lungs of Patients with Idiopathic Pulmonary Fibrosis and Systemic Sclerosis

SHIRO IMOKAWA, ATSUHIKO SATO, HIROSHI HAYAKAWA, MASATO KOTANI, TETSUMEI URANO, and AKIKAZU TAKADA

The Second Division, Department of Internal Medicine and the Second Division, Department of Physiology, Hamamatsu University School of Medicine, Hamamatsu, Japan

Although abnormalities of alveolar fibrin turnover have been reported to play a role in the development of idiopathic pulmonary fibrosis (IPF), the pathophysiological relevance remains unclear. We therefore investigated the localization of tissue factor (TF) and fibrin deposition in patients with IPF using immunohistochemistry and compared the results with those from patients who had interstitial pneumonia associated with systemic sclerosis (IP-SSc) and idiopathic bronchiolitis obliterans with organizing pneumonia (BOOP). Expression of TF-mRNA was also assessed, using in situ hybridization with a digoxigenin-labeled cRNA probe. In patients with IPF, IP-SSc, and idiopathic BOOP, the TF antigen was positively stained in type II pneumocytes and in some alveolar macrophages. The fibrin antigen was stained in the type II pneumocytes and the adjacent area. Tissue factor-mRNA was expressed in the type II pneumocytes and in some alveolar macrophages. Neither TF antigens nor TF-mRNA were detected in the normal lung. These results indicate that type II pneumocytes are a major source of TF, suggesting that TF production in these cells is closely related to fibrin deposition in the lungs of people with these diseases.

This article has been cited by other articles:

				A U Wells, N Hirani, and on behalf of the BTS Interstitial Lung Disease Gui Interstitial lung disease guideline Thorax, September 1, 2008; 63(Suppl_5): v1 - v58. [Full Text] [PDF]

				P. Rogliani, M. Mura, M. Assunta Porretta, and C. Saltini Review: New perspectives in the treatment of idiopathic pulmonary fibrosis Therapeutic Advances in Respiratory Disease, April 1, 2008; 2(2): 75 - 93. [Abstract] [PDF]

				R. Hajj, T. Baranek, R. Le Naour, P. Lesimple, E. Puchelle, and C. Coraux Basal Cells of the Human Adult Airway Surface Epithelium Retain Transit-Amplifying Cell Properties Stem Cells, January 1, 2007; 25(1): 139 - 148. [Abstract] [Full Text] [PDF]

				H. Kubo, K. Nakayama, M. Yanai, T. Suzuki, M. Yamaya, M. Watanabe, and H. Sasaki Anticoagulant Therapy for Idiopathic Pulmonary Fibrosis Chest, September 1, 2005; 128(3): 1475 - 1482. [Abstract] [Full Text] [PDF]

				J. C. Grutters and R. M. du Bois Genetics of fibrosing lung diseases Eur. Respir. J., May 1, 2005; 25(5): 915 - 927. [Abstract] [Full Text] [PDF]

				D. C.J. Howell, R. H. Johns, J. A. Lasky, B. Shan, C. J. Scotton, G. J. Laurent, and R. C. Chambers Absence of Proteinase-Activated Receptor-1 Signaling Affords Protection from Bleomycin-Induced Lung Inflammation and Fibrosis Am. J. Pathol., May 1, 2005; 166(5): 1353 - 1365. [Abstract] [Full Text] [PDF]

				R.C. Chambers Role of coagulation cascade proteases in lung repair and fibrosis Eur. Respir. J., September 20, 2003; 22(44_suppl): 33s - 35s. [Full Text] [PDF]

				N. Kaminski, J. A. Belperio, P. B. Bitterman, L. Chen, S. W. Chensue, A. M.K. Choi, S. Dacic, J. H. Dauber, R. M. du Bois, J. J. Enghild, et al. Idiopathic Pulmonary Fibrosis Am. J. Respir. Cell Mol. Biol., September 1, 2003; 29(3): S1 - 105. [Full Text] [PDF]

				D. C. J. Howell, N. R. Goldsack, R. P. Marshall, R. J. McAnulty, R. Starke, G. Purdy, G. J. Laurent, and R. C. Chambers Direct Thrombin Inhibition Reduces Lung Collagen, Accumulation, and Connective Tissue Growth Factor mRNA Levels in Bleomycin-Induced Pulmonary Fibrosis Am. J. Pathol., October 1, 2001; 159(4): 1383 - 1395. [Abstract] [Full Text]

				M. Selman, T. E. King Jr., and A. Pardo Idiopathic Pulmonary Fibrosis: Prevailing and Evolving Hypotheses about Its Pathogenesis and Implications for Therapy Ann Intern Med, January 16, 2001; 134(2): 136 - 151. [Abstract] [Full Text] [PDF]

				V. A. Ploplis, J. Wilberding, L. McLennan, Z. Liang, I. Cornelissen, M. E. DeFord, E. D. Rosen, and F. J. Castellino A Total Fibrinogen Deficiency Is Compatible with the Development of Pulmonary Fibrosis in Mice Am. J. Pathol., September 1, 2000; 157(3): 703 - 708. [Abstract] [Full Text] [PDF]

				J.-F. Cordier Rare diseases bullet 8: Organising pneumonia Thorax, April 1, 2000; 55(4): 318 - 328. [Full Text]

				K. Ide, H. Hayakawa, T. Yagi, A. Sato, Y. Koide, A. Yoshida, M. Uchijima, T. Suda, K. Chida, and H. Nakamura Decreased Expression of Th2 Type Cytokine mRNA Contributes to the Lack of Allergic Bronchial Inflammation in Aged Rats J. Immunol., July 1, 1999; 163(1): 396 - 402. [Abstract] [Full Text] [PDF]